Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 1.32% | 3.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.32% | 3.66% | |||
| Cost of Revenue | 0.87% | 5.13% | |||
| Gross Profit | 1.55% | 2.91% | |||
| SG&A Expenses | 0.00% | 4.17% | |||
| Depreciation & Amortization | -1.41% | -0.93% | |||
| Other Operating Expenses | 163.83% | -192.16% | |||
| Total Operating Expenses | 1.43% | 2.66% | |||
| Operating Income | 0.85% | 8.08% | |||
| Income Before Tax | 12.11% | 9.69% | |||
| Income Tax Expenses | -66.42% | 0.50% | |||
| Earnings from Continuing Operations | 46.76% | 14.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -650.00% | 66.67% | |||
| Net Income | 45.43% | 14.92% | |||
| EBIT | 0.85% | 8.08% | |||
| EBITDA | -0.45% | 5.49% | |||
| EPS Basic | 45.48% | 14.95% | |||
| Normalized Basic EPS | 8.58% | 7.45% | |||
| EPS Diluted | 45.59% | 15.25% | |||
| Normalized Diluted EPS | 8.54% | 7.58% | |||
| Average Basic Shares Outstanding | -0.04% | -0.02% | |||
| Average Diluted Shares Outstanding | -0.02% | -0.14% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.31% | -0.13% | |||